NASDAQ NMS - GLOBAL MARKET · IVVD
-3.08% · -$0.0299 · Vol 4.1M
Invivyd Inc

Invivyd Inc

Biotechnology
$0.9400
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is IVVD moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Invivyd Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2021
Employees
122
Country
US

Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.9645
Day high
$0.9850
Day low
$0.9106
Previous close
$0.9699
52W high
$0.9850
-4.57% from high
52W low
$0.7820
78% of range
Market cap
$285.7M
EPS
$-0.4500
Shares out
294.6M
Volume
4.1M
VWAP
$0.9468
Price history computed in-house
1W
+12.29%
SMA 50 $0.8782 · above
SMA 200 $0.8782 · above
52W position 78%
Veridion warehouse edge

Warehouse intelligence for IVVD.

Veridion Score
39
0: 721: 622: 293: 104: 815: Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

IVVD insider activity

Invivyd Inc

Score
Coverage building
Pressure
Net selling
Filings
21
Buys / sells
1 / 20
Net value
-$396K
Insiders
6
Named filers
AI
Allen Robert D. III
Insider
Leadership
GJ
Green Julie
Insider
Leadership
LE
Lee Timothy Edward
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net selling: -$396K across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-02-182026-02-18Allen Robert D. IIIInsidersell$1.5819,392114,487$31KSEC Form 4
2026-02-182026-02-18Green JulieInsidersell$1.5820,964107,717$33KSEC Form 4
2026-02-182026-02-18Lee Timothy EdwardInsidersell$1.5820,964117,717$33KSEC Form 4
2026-02-182026-02-18Andersen JillInsidersell$1.5834,939181,736$55KSEC Form 4
2026-02-182026-02-18Duke William E.Insidersell$1.5820,964107,717$33KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 16 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

IVVD contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for IVVD in this window.
Lobbying spend

IVVD lobbying filings, year to date.

Registered lobbying filings matched to Invivyd Inc.

$100.0K
Refresh interval: 12hSource: LDA disclosure filings
Health Issues
Filing
$60.0K
INVIVYD

FORBES-TATE

Apr 20, 2026
Filing
$20.0K
INVIVYD INC.

INVIVYD, INC.

Apr 23, 2026
Filing
$20.0K
INVIVYD INC.

INVIVYD, INC.

Feb 20, 2026
Latest news · IVVD
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for IVVD.
Options
Sovereign unlock shows live options positioning for IVVD.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.